The number of risk factors is the strongest predictor of prostate cancer mortality: multi-institutional outcomes of an extreme-risk prostate cancer cohort

被引：0
|
作者：
A. Gomez-Iturriaga
Á. Cabeza
J. Pastor
J. Jove
M. Casaña
A. G. Caamaño
J. Mengual
I. Henríquez
J. Muñoz
A. Hervás
C. G.-S. Segundo
机构：
[1] Hospital Universitario Cruces,Department of Radiation Oncology
[2] Hospital Doce de Octubre,Department of Radiation Oncology
[3] Hospital General de Valencia,Department of Radiation Oncology
[4] Hospital Germans Trias i Pujol,Department of Radiation Oncology
[5] Instituto Valenciano de Oncologia,Department of Radiation Oncology
[6] Hospital Clínico Universitario,Department of Radiation Oncology
[7] Hospital Universitario San Joan,Department of Radiation Oncology
[8] Hospital Infanta Cristina,Department of Radiation Oncology
[9] Hospital Ramón y Cajal,Department of Radiation Oncology
[10] Hospital Gregorio Marañon,Department of Radiation Oncology
来源：
Clinical and Translational Oncology | 2016年 / 18卷
关键词：
Prostate cancer; Radiotherapy; Androgen deprivation; Extreme risk; Survival; Multimodal treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1026 / 1033
页数：7
相关论文
共 50 条
  • [21] STRATIFICATION OF HIGH-RISK PROSTATE CANCER INTO PROGNOSTIC CATEGORIES; A EUROPEAN MULTI-INSTITUTIONAL STUDY
    Joniau, Steven
    Gontero, Paolo
    Briganti, Alberto
    Fieuws, Steffen
    Tombal, Bertrand
    Marchioro, Giansilvio
    Hsu, Chao-Yu
    Frea, Bruno
    Montorsi, Francesco
    Van Poppel, Hein
    Spahn, Martin
    JOURNAL OF UROLOGY, 2012, 187 (04): : E148 - E149
  • [22] TREATMENT INTENSIFICATION AND OUTCOME IN HIGH-RISK PROSTATE CANCER:A MULTI-INSTITUTIONAL CONSORTIUM ANALYSIS
    Kishan, Amar
    Karnes, R. Jeffrey
    Romero, Tahmineh
    Motterle, Giovanni
    Tendulkar, Rahul
    Klein, Eric
    Wong, J. Karen
    Horwitz, Eric
    Tward, Jonathan
    Dess, Robert
    Wedde, Trude
    Lilleby, Wolfgang
    Merrick, Gregory
    Stock, Richard
    Krauss, Daniel
    Phuoc Tran
    Moran, Brian
    Spratt, Daniel
    Stish, Bradley
    Davis, Brian
    Levin-Epstein, Rebecca
    Reddy, Chandana
    Stephenson, Andrew
    Braccioforte, Michelle
    Fiano, Ryan
    King, Christopher
    Rettig, Matt
    Steinberg, Michael
    Nickols, Nicholas
    Elashoff, David
    Demanes, D. Jeffrey
    Reiter, Robert
    Tilki, Derya
    JOURNAL OF UROLOGY, 2020, 203 : E1293 - E1293
  • [23] Stratification of High-risk Prostate Cancer into Prognostic Categories: A European Multi-institutional Study
    Joniau, Steven
    Briganti, Alberto
    Gontero, Paolo
    Gandaglia, Giorgio
    Tosco, Lorenzo
    Fieuws, Steffen
    Tombal, Bertrand
    Marchioro, Giansilvio
    Walz, Jochen
    Kneitz, Burkhard
    Bader, Pia
    Frohneberg, Detlef
    Tizzani, Alessandro
    Graefen, Markus
    van Cangh, Paul
    Karnes, R. Jeffrey
    Montorsi, Francesco
    Van Poppel, Hein
    Spahn, Martin
    EUROPEAN UROLOGY, 2015, 67 (01) : 157 - 164
  • [24] The Benefit of Whole Pelvis Radiation Therapy in Patients with High-Risk Prostate Cancer Relative to the Risk of Nodal Metastases in a Multi-Institutional Cohort
    Valle, Luca
    Xiang, Michael
    Kishan, Amar
    Romero, Tahmineh
    Wong, Jessica
    Stish, Bradley
    Spratt, Daniel
    Pilar, Avinash
    Ciezki, Jay
    Wedde, Trude
    Merrick, Gregory
    Stock, Richard
    Moran, Brian
    Phuoc Tran
    Martinez-Monge, Rafael
    Krauss, Daniel
    Ross, Ashley
    Tilki, Derya
    Tward, Jonathan
    Davis, Brian
    Steinberg, Michael
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (10): : S8 - S9
  • [25] Factors Associated with Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional Cohort
    Cooley, Lauren Folgosa
    Emeka, Adaeze A.
    Meyers, Travis J.
    Cooper, Phillip R.
    Lin, Daniel W.
    Finelli, Antonio
    Eastham, James A.
    Logothetis, Christopher J.
    Marks, Leonard S.
    Vesprini, Danny
    Goldenberg, S. Larry
    Higano, Celestia S.
    Pavlovich, Christian P.
    Chan, June M.
    Morgan, Todd M.
    Klein, Eric A.
    Barocas, Daniel A.
    Loeb, Stacy
    Helfand, Brian T.
    Scholtens, Denise M.
    Witte, John S.
    Catalona, William J.
    JOURNAL OF UROLOGY, 2021, 206 (05): : 1148 - 1155
  • [26] Risk factors for prostate cancer
    Patel, Amit R.
    Klein, Eric A.
    NATURE CLINICAL PRACTICE UROLOGY, 2009, 6 (02): : 87 - 95
  • [27] Risk factors for prostate cancer
    Amit R Patel
    Eric A Klein
    Nature Clinical Practice Urology, 2009, 6 : 87 - 95
  • [28] European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators significantly outperform the Prostate Cancer Prevention Trial (PCPT) 2.0 in the prediction of prostate cancer: a multi-institutional study
    Foley, Robert W.
    Maweni, Robert M.
    Gorman, Laura
    Murphy, Keefe
    Lundon, Dara J.
    Durkan, Garrett
    Power, Richard
    O'Brien, Frank
    O'Malley, Kieran J.
    Galvin, David J.
    Murphy, T. Brendan
    Watson, R. William
    BJU INTERNATIONAL, 2016, 118 (05) : 706 - 713
  • [29] Vitamin D levels and the risk of prostate cancer and prostate cancer mortality
    Stroomberg, Hein Vincent
    Vojdeman, Fie Juhl
    Madsen, Christian Medom
    Helgstrand, John Thomas
    Schwarz, Peter
    Heegaard, Anne-Marie
    Olsen, Anja
    Tjonneland, Anne
    Struer Lind, Bent
    Brasso, Klaus
    Jorgensen, Henrik Lovendahl
    Roder, Martin Andreas
    ACTA ONCOLOGICA, 2021, 60 (03) : 316 - 322
  • [30] Aspirin and the risk of prostate cancer mortality
    Carlo La Vecchia
    Cristina Bosetti
    Nature Reviews Clinical Oncology, 2012, 9 : 616 - 617
12345